Division of Cardiology, University of California, San Diego, CA, USA.
Emergency & Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Eur J Heart Fail. 2021 Jan;23(1):58-67. doi: 10.1002/ejhf.2012. Epub 2020 Oct 9.
Whether risk of worsening renal function (WRF) during acute heart failure (AHF) hospitalization or the association between in-hospital WRF and post-discharge outcomes vary according to left ventricular ejection fraction (LVEF) is uncertain. We assessed incidence of WRF, factors related to its development and impact of WRF on post-discharge outcomes across the spectrum of LVEF in patients enrolled in RELAX-AHF-2.
A total of 6112 patients who had LVEF measured on admission and renal function determined prospectively during hospitalization were included. WRF, defined as a rise in serum creatinine ≥0.3 mg/dL from baseline through day 5, occurred in 1722 patients (28.2%). Incidence increased progressively from lowest to highest LVEF quartile (P < 0.001). After baseline adjustment, WRF risk in Q4 (LVEF >50%) remained significantly greater than in Q1 (LVEF ≤29%; hazard ratio 1.2, 95% confidence interval 1-1.43; P = 0.050). Age and comorbidity burden including chronic kidney disease increased as LVEF increased. Neither admission haemodynamic abnormalities, extent of diuresis during hospitalization nor residual congestion explained the increased incidence of WRF in patients with higher LVEF. Serelaxin treatment and diuretic responsiveness were associated with reduced risk of WRF in all LVEF quartiles. WRF in patients in the upper three LVEF quartiles increased risk of post-discharge events.
Worsening renal function incidence during AHF hospitalization increases progressively with LVEF. Greater susceptibility of patients with higher LVEF to WRF appears more related to their advanced age and worse underlying kidney function rather than haemodynamic or treatment effects. WRF is associated with increased risk of post-discharge events except in patients in the lowest LVEF quartile.
在急性心力衰竭(AHF)住院期间,肾功能恶化(WRF)的风险或住院期间 WRF 与出院后结局之间的关系是否因左心室射血分数(LVEF)而异尚不确定。我们评估了 RELAX-AHF-2 研究中纳入的患者中,在整个 LVEF 范围内,WRF 的发生率、与其发展相关的因素以及 WRF 对出院后结局的影响。
共纳入 6112 例患者,这些患者在入院时测量 LVEF,并在住院期间前瞻性地测定肾功能。WRF 定义为血清肌酐从基线上升≥0.3mg/dL 至第 5 天,共有 1722 例患者(28.2%)发生。发生率从最低到最高 LVEF 四分位数逐渐增加(P<0.001)。在基线调整后,Q4(LVEF>50%)的 WRF 风险仍明显大于 Q1(LVEF≤29%;危险比 1.2,95%置信区间 1-1.43;P=0.050)。年龄和合并症负担(包括慢性肾脏病)随着 LVEF 的增加而增加。入院时血流动力学异常、住院期间利尿程度或残留充血均不能解释 LVEF 较高患者 WRF 发生率增加的原因。雷尔昔生治疗和利尿剂反应性与所有 LVEF 四分位数的 WRF 风险降低相关。在上三个 LVEF 四分位数的患者中,WRF 增加了出院后事件的风险。
在 AHF 住院期间,肾功能恶化的发生率随着 LVEF 的增加而逐渐增加。LVEF 较高的患者对 WRF 的敏感性增加似乎与他们的高龄和较差的基础肾功能有关,而不是与血流动力学或治疗效果有关。除了 LVEF 最低四分位数的患者外,WRF 与出院后事件的风险增加有关。